Back to Alzheimers Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05395559

NCT05395559
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You speak Dutch
  • You are currently staying in hospital
  • You are 65 years old or older

Who may not be able to join:

  • You are unable to complete a short memory and thinking test called the Mini-Cog, for example because of vision problems, significant hearing loss, being too unwell, or being unable to speak or write
  • You are required to be kept in medical isolation from other patients
  • You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University Medical Center Groningen
Registry
clinicaltrials_gov
Start date
21 September 2022
Est. completion
21 September 2022

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Percentage of hospitalized patients aged 65 years or older with cognitive impairment; Percentage of hospitalized patients aged 65 years or older with cognitive impairment that has been recognized by nurses, physicians, both their nurse and physician, and either their nurse or physician

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov